ATC Group: M01AC Oxicams

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of M01AC in the ATC hierarchy

Level Code Title
1 M Musculo-skeletal system
2 M01 Antiinflammatory and antirheumatic products
3 M01A Antiinflammatory and antirheumatic products, non-steroids
4 M01AC Oxicams

Group M01AC contents

Code Title
M01AC01 Piroxicam
M01AC02 Tenoxicam
M01AC04 Droxicam
M01AC05 Lornoxicam
M01AC06 Meloxicam
M01AC56 Meloxicam, combinations

Active ingredients in M01AC

Active Ingredient Description
Ampiroxicam
Lornoxicam

Lornoxicam is a non-steroidal anti-inflammatory drug with analgesic properties and belongs to the class of oxicams. Lornoxicams mode of action is mainly related to the inhibition of the prostaglandin synthesis (inhibition of the cyclooxygenase enzyme) leading to desensitisation of peripheral nociceptors and consequently inhibition of inflammation. A central effect on nociception, which seems to be independent of anti-inflammatory effects has also been suggested.

Meloxicam

Meloxicam is a non-steroidal anti-inflammatory drug (NSAID) of the oxicam family, with anti-inflammatory, analgesic and antipyretic properties. The anti-inflammatory activity of meloxicam has been proven in classical models of inflammation. As with other NSAID, its precise mechanism of action remains unknown. However, there is at least one common mode of action shared by all NSAID (including meloxicam): inhibition of the biosynthesis of prostaglandins, known inflammation mediators.

Piroxicam

Piroxicam is a non-steroidal anti-inflammatory agent with analgesic and antipyretic activity. It is effective regardless of the aetiology of the inflammation.

Tenoxicam

Tenoxicam is a non-steroidal anti-inflammatory drug (NSAID) which has anti-inflammatory, analgesic, antipyretic properties and it also inhibits platelet aggregation.

Related product monographs

Title Information Source Document Type  
FELDENE Capsule, FELDENE D Tablet Pharmaceutical Benefits Scheme (AU) MPI, EU: SmPC
FLAMARYX Tablet Health Products Regulatory Authority (ZA) MPI, Generic
MELCAM Tablet Health Products Regulatory Authority (IE) MPI, EU: SmPC
MELOREX Tablet Medicines and Medical Devices Safety Authority (NZ) MPI, EU: SmPC
MELOX Tablet Υπουργείο Υγείας (CY) MPI, EU: SmPC
MELOXICAM Orodispersible tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
MOBIC Tablet FDA, National Drug Code (US) MPI, US: SPL/PLR
MOBIFLEX Film-coated tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
MOXICAM Tablet MPI, EU: SmPC
PIXICAM Dispersible tablet Health Products Regulatory Authority (ZA) MPI, Generic
PYROCAPS Capsule Health Products Regulatory Authority (ZA) MPI, Generic
SOTILEN Capsule Υπουργείο Υγείας (CY) MPI, EU: SmPC
XEFO Film-coated tablets Health Products Regulatory Authority (IE) MPI, EU: SmPC
XEFO Powder and solvent for solution for injection MPI, EU: SmPC